Skip to main content
HLB Life Science CO.,LTD. logo

HLB Life Science CO.,LTD. — Investor Relations & Filings

Ticker · 067630 ISIN · KR7067630004 LEI · 9884006PTFB20S9PS149 KO Manufacturing
Filings indexed 396 across all filing types
Latest filing 2019-01-04 Director's Dealing
Country KR South Korea
Listing KO 067630

About HLB Life Science CO.,LTD.

https://www.hlb-lsmc.com/

HLB Life Science is a specialized pharmaceutical and biotechnology firm focused on the development of innovative anti-cancer medications and the manufacturing of medical devices. The company's research and development efforts center on targeted therapies and cell therapies for oncology. In parallel, it develops, manufactures, and distributes in vitro diagnostic (IVD) medical devices and quasi-drugs. The company's portfolio also includes the clinical development of anti-cancer drugs for animals, aiming to provide comprehensive solutions across human and animal health.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form used in South Korea (often referred to as a 'Director's Dealing' or 'Insider Trading' report) where company executives or major shareholders report changes in their shareholdings. Based on the provided definitions, this aligns perfectly with the 'Director's Dealing' (DIRS) category.
2019-01-04 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the closure of the shareholder register for the purpose of determining shareholders eligible to vote at the upcoming Annual General Meeting (AGM). It does not contain the full report or proxy materials, but rather serves as a formal regulatory notice of a corporate action. Given it does not fit into specific categories like dividend announcements or share issues, it falls under the general regulatory filing category.
2018-12-14 Korean
기업설명회(IR)개최
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding an upcoming Investor Relations (IR) conference. It provides details such as the date, location, purpose, and method of the event (participation in the Hana Financial Investment IR Conference). Since it is a brief notification of an event rather than the actual presentation slides or a comprehensive report, it falls under the category of a regulatory announcement regarding corporate activities.
2018-12-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (DART). This type of filing is a mandatory disclosure for company insiders (directors/executives) to report their personal share transactions and holdings. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers insider trades and changes in share ownership by company management.
2018-11-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서), which is a standard regulatory filing in South Korea (DART system) used to disclose insider shareholdings and changes in ownership. This falls under the category of Director's Dealing (DIRS) as it reports personal share transactions and ownership status by company executives.
2018-11-15 Korean
분기보고서 (2018.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for HLB Life Science Co., Ltd. for the period ending September 30, 2018. It contains comprehensive financial statements, management discussion, and corporate information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2018
2018-11-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.